Deliver trusted results with dual targets across a wide linear range and all major HBV genotypes.
The Aptima® HBV Quant Assay is a molecular HBV treatment management assay with dual-target design. It helps providers guide treatment management for patients with chronic hepatitis B infection who are undergoing antiviral therapy.
Quantitation Across Genotypes
Validated performance across HBV genotypes A – H, with added tolerance to mutations.
Allows laboratorians to deliver trusted results from baseline throughout treatment despite low or high viral loads.